Biofrontera (BFRIW) Competitors $0.08 +0.02 (+26.25%) As of 09:31 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock BFRIW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BTMDW, BCTXW, and CELUWShould you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Biofrontera vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, community ranking, valuation, media sentiment, analyst recommendations and risk. Does the MarketBeat Community favor ATNFW or BFRIW? 180 Life Sciences and Biofrontera both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ABiofronteraN/AN/A Is ATNFW or BFRIW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Biofrontera N/A N/A N/A Does the media favor ATNFW or BFRIW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Biofrontera Neutral Which has higher earnings and valuation, ATNFW or BFRIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ABiofrontera$37.32MN/AN/AN/AN/A SummaryBiofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Remove Ads Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRIW vs. The Competition Export to ExcelMetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.24B$5.57B$7.55BDividend YieldN/A2.92%5.35%4.04%P/E RatioN/A4.2722.9818.17Price / SalesN/A521.89362.2486.05Price / CashN/A10.2538.1634.64Price / BookN/A6.196.534.02Net IncomeN/A$20.70B$3.21B$247.18M7 Day PerformanceN/A-1.65%-5.94%-5.78%1 Month PerformanceN/A-3.63%-0.22%-6.84%1 Year PerformanceN/A89.79%6.46%-3.73% Biofrontera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRIWBiofronteraN/A$0.08+26.2%N/A+20.4%$0.00$37.32M0.0070Gap UpATNFW180 Life SciencesN/A$0.01flatN/A-41.7%$0.00N/A0.007Positive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$9.09-1.6%$30.50+235.5%N/A$0.00N/A0.0018Analyst ForecastNews CoverageGap DownAEHAWAesther Healthcare AcquisitionN/A$0.02+11.8%N/A-92.5%$0.00N/A0.002AIMDWAinosN/A$0.11-34.3%N/A+71.1%$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$2.36-9.6%N/A-53.3%$0.00$391.87M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/AN/A$0.00N/A0.0015BTMDWbioteN/A$0.07flatN/A-88.4%$0.00$197.19M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-7.1%N/A-91.6%$0.00N/A0.008Positive NewsGap DownCELUWCelularityN/A$0.05+25.0%N/A-13.8%$0.00$48.20M0.00220Gap Up Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRIW) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BFRIW Stock Free BFRIW Stock Alerts